Libra Therapeutics @LibraBiotech

Restoring cellular balance: developing novel therapeutics for #neurodegenerativedisease. #ALS #dementia #Alzheimers #Parkinsons #Huntingtons libratherapeutics.com San Diego, California Joined September 2020

Tweets

9
Followers

34
Following

11
Likes

7

Libra Therapeutics @LibraBiotech

10 months ago

We’re excited to welcome Dr. Shawn A. Scranton as our new President & CEO! With 30+ years of experience, he’ll lead us in advancing LBR-2950 & other therapies for ALS & #Parkinsons. Thanks to Isaac Veinbergs, now EVP & CBO, for his continued leadership. libratx.com/300

0 0 0 23 0

Download Image

Libra Therapeutics @LibraBiotech

11 months ago

Thanks @biotechtvhq for chatting about our progress to the clinic with our novel therapeutic approach to clear out misfolded and toxic proteins that accumulate in the brain with the potential to treat a number of neurodegenerative diseases. biotechtv.com/post/libra-the…

BiotechTV @BiotechTV

11 months ago

0 0 5 1K 1

Download Video

0 0 0 25 0

Libra Therapeutics @LibraBiotech

4 years ago

Today we announced the appointment of Philip Lambert, Ph.D., as Libra’s first CSO. He will lead the development of our novel drug candidates with the potential to restore cellular balance and treat #neurodegenerativedisease. libratherapeutics.com/post/libra-the… #sandiego #biotech

0 0 2 0 0

Download Image

Libra Therapeutics @LibraBiotech

4 years ago

We are excited to announce that we have joined the community at JLABS @ San Diego. jlabs.jnjinnovation.com/JLABSNavigator…. #JLABS #JLABSSD #sandiego #neurodegenerativedisease #neurodegeneration #drugdiscovery #drugdevelopment #biotech

1 1 1 0 0

Download Image

Libra Therapeutics @LibraBiotech

5 years ago

We just posted a new #job opening for Vice President, Biology. If you think you are a fit or know someone who is, find out more here. libratherapeutics.com/careers #sandiego #biotech #innovation #biology #careers #jobannouncement #jobopening #careeropportunity #sandiego

0 1 1 0 0

Download Image

Jonathan Wosen, Ph.D. @JonathanWosen

5 years ago

“Being involved in therapeutic aspects of neurological disease has been at the core of my purpose” -- Isaac Veinbergs, CEO of Libra Therapeutics, which raised $29M in a Series A round. @sdbn @big4bioSD @mcdiana @grobbins @jyingling @LibraBiotech

The San Diego Union-Tribune @sdut

5 years ago

0 6 22 0 0

Download Image

1 2 5 0 0

Frank Vinluan @frankvinluan

5 years ago

In #biotech #startup news, @LibraBiotech emerged from stealth w/ $29M and 3 programs in development, initially for #ALS. The firm says its approach of restoring balance to cellular proteins could also apply to other neuro diseases... xconomy.com/san-diego/2020…

1 1 1 0 0

Inside Precision Medicine @Inside_PM

5 years ago

.@LibraBiotech Launches with $29M Series A Financing. Learn more: ow.ly/EZfd50BAfpR #neurodegenerativediseases

0 1 1 0 0

Libra Therapeutics @LibraBiotech

5 years ago

We are excited to announce the official company launch today with $29M to develop novel drugs for #neurodegenerativediseases. Thanks to Axxam and our investors: BIVF, @epidarex, Sante, Yonjin Venture, Dolby Family Ventures, and Sixty Degree Capital. libratherapeutics.com/post/libra-lau…